Published in J R Coll Gen Pract on August 01, 1975
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis (2008) 4.46
Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ (2000) 3.40
Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother (1995) 2.16
A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity (2011) 2.15
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis (2009) 2.13
Acute herpes zoster and postherpetic neuralgia: effects of acyclovir and outcome of treatment with amitriptyline. Br J Gen Pract (1992) 2.04
Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open (2014) 1.81
Update on herpes zoster vaccination: a family practitioner's guide. Can Fam Physician (2011) 1.74
Vaccination against Herpes Zoster and Postherpetic Neuralgia. J Infect Dis (2008) 1.70
Natural history of pain following herpes zoster. Pain (2006) 1.66
Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons. J Virol (2006) 1.54
Epidemiology of shingles. J R Soc Med (1990) 1.52
Treatment of shingles and post-herpetic neuralgia. BMJ (1989) 1.51
Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease. Aliment Pharmacol Ther (2012) 1.49
Quantification of risk factors for herpes zoster: population based case-control study. BMJ (2014) 1.34
A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax. Clin Vaccine Immunol (2007) 1.25
Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005. BMC Fam Pract (2008) 1.18
Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br J Gen Pract (1995) 1.11
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ (2012) 1.05
Complications of varicella zoster virus reactivation. Curr Treat Options Neurol (2013) 1.04
Characterization of the host immune response in human Ganglia after herpes zoster. J Virol (2010) 1.00
Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis (2011) 0.99
The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. Z Gesundh Wiss (2011) 0.98
Somatosensory findings in postherpetic neuralgia. J Neurol Neurosurg Psychiatry (1990) 0.97
Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or older. Clin Vaccine Immunol (2009) 0.96
Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health (2015) 0.96
Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004). BMC Infect Dis (2009) 0.94
Incidence of herpes zoster and associated events including stroke-a population-based cohort study. BMC Infect Dis (2015) 0.93
Treatment of herpes zoster. Can Fam Physician (2008) 0.92
Management and prevention of herpes zoster: A Canadian perspective. Can J Infect Dis Med Microbiol (2010) 0.92
Challenges in the development of novel treatment strategies for neuropathic pain. NeuroRx (2005) 0.90
Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Serv Res (2013) 0.89
Cost-effectiveness of vaccination against herpes zoster. Hum Vaccin Immunother (2014) 0.88
The cytoplasmic domain of varicella-zoster virus glycoprotein H regulates syncytia formation and skin pathogenesis. PLoS Pathog (2014) 0.88
The challenging patient with varicella-zoster virus disease. Neurol Clin Pract (2013) 0.88
Vaccination against herpes zoster in developed countries: state of the evidence. Hum Vaccin Immunother (2013) 0.87
Postherpetic neuralgia: from preclinical models to the clinic. Neurotherapeutics (2009) 0.86
Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: a randomized study of a single dose vs. two different two-dose schedules. Hum Vaccin Immunother (2013) 0.82
Disseminated herpes zoster ophthalmicus in an immunocompetent 8-year old boy. Clin Pract (2013) 0.82
Prevalence and healthcare utilization of herpes zoster and postherpetic neuralgia in South Korea: disparity among patients with different immune statuses. Epidemiol Health (2014) 0.81
The PINE study: rationale and design of a randomised comparison of epidural injection of local anaesthetics and steroids versus care-as-usual to prevent postherpetic neuralgia in the elderly [ISRCTN32866390]. BMC Anesthesiol (2004) 0.81
Epidemiology of Postherpetic Neuralgia in Korea: An Electronic Population Health Insurance System Based Study. Medicine (Baltimore) (2016) 0.79
One-year follow-up of patients with long-lasting post-herpetic neuralgia. BMC Infect Dis (2014) 0.79
Ramsay-Hunt syndrome complicating osteonecrosis of edentulous maxilla and mandible: report of a rare case. J Maxillofac Oral Surg (2009) 0.79
Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany. Hum Vaccin Immunother (2015) 0.78
Cost-effectiveness of a herpes zoster vaccination program among the French elderly people. Hum Vaccin Immunother (2016) 0.78
Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) Vaccination. Front Immunol (2015) 0.77
The Shozu Herpes Zoster (SHEZ) study: rationale, design, and description of a prospective cohort study. J Epidemiol (2012) 0.77
Immunogenicity and safety of ZOSTAVAX(®) approaching expiry potency in individuals aged ≥50 years. Hum Vaccin (2011) 0.77
Vaccination to prevent zoster in the elderly. Epidemiol Infect (2007) 0.77
Postherpetic neuralgia. BMJ Clin Evid (2010) 0.76
Vibrio vulnificus necrotizing fasciitis preceding herpes zoster. Proc (Bayl Univ Med Cent) (2013) 0.75
Varicella-zoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures. J Virol (2013) 0.75
Statin use and the risk of herpes zoster: a nested case-control study using primary care data from the U.K. Clinical Research Practice Datalink. Br J Dermatol (2016) 0.75
Postherpetic neuralgia. BMJ Clin Evid (2007) 0.75
The outcome of patients with herpes zoster. AMA Arch Derm (1957) 4.68
The natural history of herpes zoster. J Am Med Assoc (1957) 4.10
Epidemic mechanisms of type A influenza. J Hyg (Lond) (1979) 2.85
The role of season in the epidemiology of influenza. J Hyg (Lond) (1981) 2.72
A respiratory virus study in Great Britain: review and evaluation. Prog Med Virol (1969) 2.34
Hong Kong influenza variant. Br Med J (1971) 1.52
First outbreak of Hong Kong influenza in a general practice population in Great Britain. A field and laboratory study. Br Med J (1970) 1.40
Streptococcus pyogenes in the throat: a study in a small population, 1962-1975. J Hyg (Lond) (1981) 1.39
A new concept of the epidemic process of influenza A virus. Epidemiol Infect (1987) 1.29
The definition of acute respiratory illnesses in general practice. Postgrad Med J (1973) 1.24
Recognition of historic influenza epidemics from parish burial records: a test of prediction from a new hypothesis of influenzal epidemiology. J Hyg (Lond) (1983) 1.04
A long-term study of acute respiratory diseases in a natural community. Proc R Soc Med (1966) 0.98
The spread of type A influenza. J R Coll Gen Pract (1985) 0.97
Age and secular distributions of virus-proven influenza patients in successive epidemics 1961-1976 in Cirencester: epidemiological significance discussed. J Hyg (Lond) (1984) 0.92
Parainfluenza virus infections in the Cirencester Survey: seasonal and other characteristics. J Hyg (Lond) (1981) 0.92
Protection against Hong Kong influenza. Br Med J (1972) 0.88
The epidemiology of viruses: antigenicity and evolution. Proc R Soc Med (1969) 0.80
The method of transmission of epidemic influenza: further evidence from archival mortality data. J Hyg (Lond) (1986) 0.78
Andrewes versus influenza: discussion paper. J R Soc Med (1986) 0.75
Herpes zoster in the elderly. Geriatrics (1967) 0.75
Antigenicity and evolution. Practitioner (1969) 0.75
Letter: Zoster in three children in family. Br Med J (1974) 0.75
Herpes zoster--a parasitic fossil. Nurs Times (1976) 0.75
An epidemic in Hampshire and Gloucestershire. Lancet (1973) 0.75
Toxicity of benorylate. Br Med J (1973) 0.75